Home
Joshua T. Brumm, CEO & President: Dyne Therapeutics DYN Sell · Filed 24/03/12
Trade details
- Type
- Insider sale
- Amount
- $5,116,621.4
- Shares · price
- 202,238 sh · $25.30 a share
- Held after
- 715,490 sh
- Trade date
- 24/03/08
- Filed
- 24/03/12
- Days to filing
- 4 days
Sold 22.0% of holdings
- Share of holding sold
- 22.0%
Dyne Therapeutics trades, last 26 weeks
What else happened in Dyne Therapeutics around then
Filed or reported within 30 days of the trade day · 24/02/07~24/04/07Joshua T. Brumm's recent trades
- Joshua T. Brumm
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 planCrescent Biopharma
CBIO
$154.8K
9,013 sh
$154.8K
Filed 09/17
Traded 09/18
- Joshua T. Brumm
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 planCrescent Biopharma
CBIO
$33.3K
1,771 sh
$33.3K
Filed 09/16
Traded 09/16
- Joshua T. Brumm
Sell10b5-1 planCrescent Biopharma
Sell10b5-1 planCrescent Biopharma
CBIO
$761.1K
42,305 sh
$761.1K
Filed 06/23
Traded 06/22
- Joshua T. Brumm
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$4.3M
160,670 sh
$4.3M
Filed 24/03/12
Traded 24/03/08
- Joshua T. Brumm
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$1M
40,072 sh
$1M
Filed 24/03/12
Traded 24/03/11
